Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

Buenos Aires - Delayed Quote ARS

Merck & Co., Inc. (MRK.BA)

Compare

22,375.00

+425.00

+(1.94%)

At close: February 28 at 4:59:07 PM GMT-3

Is Merck & Co., Inc. (MRK) the Best Magic Formula Stock for 2025?

We recently published a list of 10 Best Magic Formula Stocks for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best magic formula stocks for 2025. The Magic Formula, as defined by Joel Greenblatt in his book The Little Book that Beats the Market, entails […]

Insider Monkey 18 hours ago

MRK
Q4 2024 OPKO Health Inc Earnings Call

Q4 2024 OPKO Health Inc Earnings Call

Thomson Reuters StreetEvents 22 hours ago

OPK

PFE

MRK
Merck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?

We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider selling the same.

Zacks 22 hours ago

MRK
Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

It's been a good week for Merck & Co., Inc. ( NYSE:MRK ) shareholders, because the company has just released its latest...

Simply Wall St. yesterday

MRK
Merck & Co., Inc. (MRK): One of the Best Vaccine Stocks to Buy According to Hedge Funds

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other best vaccine stocks to buy now. What Will Trump’s Tariffs Mean for the Pharma Industry? On February […]

Insider Monkey yesterday

MRK
3 Leading Dividend Stocks To Consider With Up To 5.6% Yield

As U.S. markets experience a slight rebound with the S&P 500 and Nasdaq Composite snapping a four-day losing streak, investors continue to navigate economic uncertainties and policy impacts from the current administration. In this environment, dividend stocks can offer stability and potential income, making them an attractive option for those looking to balance growth with regular returns.

Simply Wall St. 2 days ago

MRK

HVT

HVT-A
Is Merck & Co., Inc. (MRK) the Best Retirement Stock to Buy According to Hedge Funds?

We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best retirement stocks to buy according to hedge funds. After much suspense, the US Federal Reserve finally began cutting […]

Insider Monkey 2 days ago

MRK
Why Polaris, Merck, And Skyworks Solutions Are Winners For Passive Income

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Polaris, Merck, and Skyworks Solutions have rewarded shareholders for years and recently announced dividend increases. These ...

Benzinga 2 days ago

SWKS

MRK

PII
Merck & Co., Inc. (MRK): Among Bourgeon Capital’s Top Stock Picks

We recently compiled a list of the Top 12 Stocks to Buy According to Bourgeon Capital. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks to buy according to Bourgeon Capital. Bourgeon Capital Management LLC is an investment advisory firm headquartered in Darien, […]

Insider Monkey 2 days ago

MRK
Despite delivering investors losses of 27% over the past 1 year, Merck (NYSE:MRK) has been growing its earnings

Investors can approximate the average market return by buying an index fund. When you buy individual stocks, you can...

Simply Wall St. 2 days ago

MRK
Cancer vaccines have stumbled, but the approach is gaining new steam

The number of candidates in development has nearly doubled over the past 15 years.

Pharma Voice 3 days ago

MRK
Eikon raises $351M in one of the year’s largest biotech venture rounds

The funding comes as Eikon, run by former Merck research chief Roger Perlmutter, has started a Phase 3 trial testing one of its cancer drugs.

BioPharma Dive 3 days ago

MRK
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Maybe The Ultimate Laggard’

We recently compiled a list of the Jim Cramer Remembers COVID-19 & Discusses These 11 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer recalled the stock market crash due […]

Insider Monkey 3 days ago

MRK
Wall Street Analysts See Merck (MRK) as a Buy: Should You Invest?

According to the average brokerage recommendation (ABR), one should invest in Merck (MRK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Zacks 3 days ago

MRK
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

RAHWAY, N.J., February 25, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, for the treatment of patients with resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC) as neoadjuvant treatment, then continued as adjuvant treat

Business Wire 4 days ago

MRK
5 Stocks in the Dow ETF That Survived the Worst Week Since October

Dow Jones witnesses its biggest weekly drop since October amid renewed concerns about economic growth. Let's look at the stocks that survived.

Zacks 4 days ago

VZ

^DJI

AMGN
Merck to Participate in the TD Cowen 45th Annual Health Care Conference

RAHWAY, N.J., February 24, 2025--Merck to Participate in the TD Cowen 45th Annual Health Care Conference

Business Wire 5 days ago

MRK
Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other pharmaceutical stocks. The Evolving Landscape of Healthcare and Biopharma Innovation Almost no other industry goes as far as the […]

Insider Monkey 5 days ago

MRK
Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently

We recently compiled a list of the 11 Most Expensive Stocks Insiders Are Buying Recently. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other expensive stocks. We previously covered the 10 cheapest stocks insiders are buying recently. The broader market returned around 21% over […]

Insider Monkey 6 days ago

MRK
2 Healthcare Stocks with Big Upside and 1 to Skip

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 1.7% over the last six months. This drawdown is a stark contrast from the S&P 500’s 9% gain.

StockStory 7 days ago

REGN

ZTS

MRK

Performance Overview

Return	MRK.BA	S&P 500
YTD	-4.48%	+1.24%
1-Year	-18.18%	+17.45%
3-Year	+627.31%	+36.14%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Merck & Co., Inc. (MRK.BA)

Is Merck & Co., Inc. (MRK) the Best Magic Formula Stock for 2025?

Q4 2024 OPKO Health Inc Earnings Call

Merck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?

Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Merck & Co., Inc. (MRK): One of the Best Vaccine Stocks to Buy According to Hedge Funds

3 Leading Dividend Stocks To Consider With Up To 5.6% Yield

Is Merck & Co., Inc. (MRK) the Best Retirement Stock to Buy According to Hedge Funds?

Why Polaris, Merck, And Skyworks Solutions Are Winners For Passive Income

Merck & Co., Inc. (MRK): Among Bourgeon Capital’s Top Stock Picks

Despite delivering investors losses of 27% over the past 1 year, Merck (NYSE:MRK) has been growing its earnings

Cancer vaccines have stumbled, but the approach is gaining new steam

Eikon raises $351M in one of the year’s largest biotech venture rounds

Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Maybe The Ultimate Laggard’

Wall Street Analysts See Merck (MRK) as a Buy: Should You Invest?

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

5 Stocks in the Dow ETF That Survived the Worst Week Since October

Merck to Participate in the TD Cowen 45th Annual Health Care Conference

Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently

2 Healthcare Stocks with Big Upside and 1 to Skip

Performance Overview